Inverse correlation between CD4+CD25highCD127low/- regulatory T-cells and serum immunoglobulin A in patients with new-onset ankylosing spondylitis

Journal of International Medical Research

Volumn 39, Issue 5, 2011, Pages 1968-1974

  Zhao, S S ^a   Hu, Jian Wen ^a   Wang, J ^a   Lou, X J ^a   Zhou, L L ^a  

^a AFFILIATED DONGYANG HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing Spondylitis; Disease Activity; Flow Cytometry Analysis; Immunoglobulin A; Regulatory T Cells

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 7 RECEPTOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; MALE; ONSET AGE; PERIPHERAL LYMPHOCYTE; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 80155175623     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900543     Document Type: Article

References (21)

1. Braun J, Bollow M, Neure L, et al: Use of immunohistological and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38: 499-505.
2. Sakaguchi S, Wing K, Miyara M: Regulatory T cells-a brief history and perspective. Eur J Immunol 2007; 37(suppl 1): S116-S123.
3. Lan RY, Ansari AA, Lian ZX, et al: Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005; 6: 351-363.
4. Seddiki N, Santner-Nanan B, Martinson J, et al: Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-1700.
5. Liu W, Putnam AL, Xu-Yu Z, et al: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711.
6. van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 1984: 27: 361-368.
7. Garrett S, Jenkinson T, Kennedy LG, et al: A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-2291.
8. Miyara M, Sakaguchi S: Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007; 13: 108-116.
9. Dejaco C, Duftner C, Grubeck-Loebenstein B, et al: Imbalance of regulatory T cells in human autoimmune diseases. Immunology 2006; 117: 289-300.
10. Baecher-Allan C, Brown JA, Freeman GJ, et al: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
11. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
12. Curotto de Lafaille MA, Lafaille JJ: Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009: 30: 626-635.
13. Shevach EM, Tran DQ, Davidson TS, et al: The critical contribution of TGF-ccto the induction of Foxp3 expression and regulatory T cell function. Eur J Immunol 2008; 38: 915-917.
14. Venigalla RK, Tretter T, Krienke S, et al: Reduced CD4+, CD25-T cell sensitivity to the suppressive function of CD4+, CD25high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008; 58: 2120-2130.
15. Mathew CM, Bhandarkar P, Siqueira RD, et al: Ankylosing spondylitis in females. Similarities and differences with male spondylitics. J Assoc Physicians India 1989; 37: 334-336.
16. Shodjai-Moradi E, Ebringer A, Abuljadayel I: IgA antibody response to Klebsiella in ankylosing spondylitis measured by immunoblotting. Ann Rheum Dis 1992; 51: 233-237.
17. Khalafpour S, Ebringer A, Abuljadayel I, et al: Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondytitis and rheumatoid arthritis patients measured by ELISA. Br J Rheumatol 1988; 27(suppl 2): 86-89.
18. Yuan GH, Shi GY, Ding YZ: Antibodies to Klebsiella pneumoniae in ankylosing spondylitis. Zhonghua Nei Ka Za Zhi 1993; 32: 467-469 [in Chinese, English abstract].
19. Veys EM, van Laera M: Serum IgG, IgM, and IgA levels in ankylosing spondylitis. Ann Rheum Dis 1973; 32: 493-496.
20. Cowling P, Ebringer R, Ebringer A: Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis 1980; 39: 545-549.
21. Ardiçoǧlu O, Atay MB, Ataoǧlu H, et al: IgA antibodies to Klebsiella in ankylosing spondylitis. Clin Rheumatol 1996; 15: 573-576.